Anuh Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 05-Aug-2026.
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anuh Pharma reported FY2026 revenue of ₹77,165.74 lakhs (up 16.6% YoY from ₹66,151.49 lakhs), but profit after tax declined 13.3% to ₹4,104.61 lakhs from ₹4,735.19 lakhs. EBITDA fell to ₹6,607.59 lakhs from ₹7,036.40 lakhs. The Board recommended a final dividend of ₹1.50 per equity share (30% payout on face value ₹5), pending shareholder approval at the AGM on 12th August 2026. Record date for dividend eligibility is 5th August 2026. The company also completed a 1:1 bonus share issuance in July 2025 (5,01,12,000 bonus shares allotted). Nine promoter group members holding ~0.95% stake have requested reclassification to public category. Shareholders' register will remain closed from 6th to 12th August 2026.
Profit decline despite revenue growth suggests margin pressure in FY2026. The conservative 30% dividend payout indicates cash conservation. Inventory nearly doubled to ₹14,775.50 lakhs from ₹7,448.09 lakhs, which may be a concern. The dividend yield will depend on current market price.